The Modesto Bee Local Stock Index
Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
My Watchlist
Indicators
AstraZeneca PLC ADS (NY: AZN)
50.19 USD  UNCHANGED
Official Closing Price  /  Updated: 6:40 PM EDT, Jun 19, 2013  /  Add to My Watchlist      
View: Quote News Research
Price and Volume
Detailed Quote
Chart for (: )
 
Intraday
1 Week
1 Month
3 Month
1 Year
  
Compare to:
Volume 1,171,019
Open 50.89
Bid (Size) 50.15 (100)
Ask (Size) 50.30 (100)
Prev. Close 50.19
Today's Range 50.18 - 50.99
52wk Range 42.68 - 53.45
Shares Outstanding 1,250,000,000
Dividend Yield 3.39%
Top News
More News
Top Line Results: No Cardiovascular Benefits Found For Saxagliptin
June 19, 2013
Top line results of a large phase 4 study with saxagliptin (Onglyza, Bristol-Myers Squibb and AstraZeneca) demonstrate that the drug is safe but has no cardiovascular benefits. AstraZeneca and... Read More
category NYSE:BMY , NYSE:AZN
from Forbes Real Time
An AstraZeneca And Bristol-Myers Diabetes Trial Is A Dud
June 19, 2013
In a setback to an important joint venture between Bristol-Myers Squibb and AstraZeneca, the top-line results of a large, late-stage study of their Onglyza diabetes drug failed to show superiority in... Read More
category NYSE:MRK , NYSE:BMY , NYSE:AZN
from Forbes Real Time

More News
Read More
Early Movers: FDX, ADBE DELL, BA, BBRY & More
June 19, 2013
category FedEx Corporation , Coca Cola Co , ASTRAZENECA PLC , and 24 more.
from CNBC.com News
Bristol-Myers (BMY), AstraZeneca (AZN) SAVOR-TIMI-53 Misses Primary Efficacy Endpoint in Phase 4
June 19, 2013
from StreetInsider.com News Articles
UPDATE 1-AstraZeneca, Bristol diabetes drug disappoints in key test
June 19, 2013
category companyNews
from Reuters: Company News
AstraZeneca, Bristol diabetes drug fails to show heart benefit
June 19, 2013
category companyNews
from Reuters: Company News
AstraZeneca and Bristol-Myers Squibb Announce Top Line Results for SAVOR-TIMI-53 Cardiovascular Outcomes Trial of Onglyza® (saxagliptin)
June 19, 2013
from Business Wire News Releases
The NIH Aims To Develop Drugs That Big Pharma Discarded
June 18, 2013
category NYSE:JNJ , NASDAQ:CBST , NYSE:PFE , and 2 more.
from Forbes Real Time
UPDATE 1-AstraZeneca picks site for new global home in Cambridge
June 18, 2013
category companyNews
from Reuters: Company News
AstraZeneca picks its new home in Cambridge next to top hospital
June 18, 2013
category companyNews
from Reuters: Company News
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates Bots go here